Ovarian Stimulation With Letrozole Shows No Short-Term Molecular Impact on Breast Tumors 2026
1h agoen
Source
OncoDailyOvarian Stimulation With Letrozole Shows No Short-Term Molecular Impact on Breast Tumors 2026oncodaily.comFertility preservation has become an increasingly important part of care for young women diagnosed with breast cancer. As survival continues to improve, more patients are asking not only how to […]
You might also wanna read
Preserving Fertility Before Breast Cancer Treatment
Cleveland Clinic·1mo ago
Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients
A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, a
apple.news·1mo ago
Could Ozempic Lower Breast Cancer Risk? What to Know
ELLE·8d agoAsk HN: What is the latest on treatment of Metastatic Breast Cancer?
news.ycombinator.com·1y ago
Breast Cancer and Your Bone Health: What To Know
Cleveland Clinic·1mo ago
Ovarian aging as a systemic regulator of female healthspan: A call for paradigm shift in geroscience
This Perspective article argues that the ovary should be recognized not merely as a reproductive organ but as a systemic regulator of female
plos.io·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.